Covid-19 funding round-up
Posted on 02/04/2020
There are also further opportunities at our initiatives and resources page.
If your study requires collection of samples or health data, see this information from the National Institute for Health Research – Prioritising funding and support for COVID-19 research across the UK.
Further information from KTN
Covid-19 hub page
Covid-19: response from KTN
Covid-19: round-up of initiatives and resources
Covid-19 National Contact points
Covid-19 – Help and support for businesses
Covid-19: regulatory guidance
Covid-19: product specifications
Five new Horizon 2020 coronavirus-related funding calls
Click here for full details of the new calls: all close at 5pm Brussels time on 11th June 2020. UK companies are still eligible for H2020 funding and are encouraged to apply: contact our Health or European Programmes teams if you have any queries.
Repurposing of manufacturing for vital medical supplies and equipment (SC1-PHE-CORONAVIRUS-2020-2A)
This focus area addresses any manufacturer able to deliver demonstrators of a flexible 48-hour industrial response capability at scale, to cope with sudden spikes in demand of strategic products (for instance medical equipment such as PPE, respirators), for requalification or release of production lines. Open Innovation Testbeds, laboratories, other technology infrastructures and maker communities may in particular be relevant.
Recommended grant amount: €5m-€6m, but applications for other amounts are welcome.
Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL) (SC1-PHE-CORONAVIRUS-2020-2B)
This topic has two strands:
Support solutions that are close-to-market (TRL 7) in one of the COVID-19 areas mentioned and that have already received, or are about to receive, the CE marking to proceed to large scale testing, piloting and deployment operations in critical healthcare areas (or wherever else is relevant) (type 1);
Support market innovation (from lab-to-fab) for further developing and maturing innovative solutions that have already been validated in lab environments (TRL 6-7 or higher) with the aim to help accelerate developments and achieve conformity assessment (CE marking) (type 2).
Recommended grant: €2m-€5m (or up to €10m with financial support from third parties)
Behavioural, social and economic impacts of the outbreak response (SC1-PHE-CORONAVIRUS-2020-2C)
Proposals should focus on lessons learnt: they should i) address how to mitigate social and economic impacts of the outbreak response related to health systems; ii) identify non-intended consequences of epidemic-control decisions; and iii) provide answers to social, including gendered, dynamics of the outbreak and the related public health response. Proposals should analyse the effects and efficiency of these responses (including resilience factors), democratic governance, multi-level cooperation, the critical gaps and the various exit strategies, their underlying methodologies and regional adaptations. Proposals are expected to develop guidelines and best ‘next practices’, and implement interventions to mitigate impacts and boost wellbeing.
Recommended grant: €4m-€10m
Pan-European COVID-19 cohorts (SC1-PHE-CORONAVIRUS-2020-2D)
Proposals submitted under this expression of interest are expected to establish new and/or build on existing large-scale cohorts to rapidly advance the knowledge on the control of the SARS-CoV-2 infection, develop evidence-based recommendations for effective prevention of the spreading, protection of the population in the coming months/years, and optimized treatment of the COVID-19 patients. The population-based cohorts should also inform on longer-term consequences of COVID-19 on health and well-being of individuals.
Recommended grant: €15m-€20m
Networking of existing EU and international cohorts of relevance to COVID-19 (SC1-PHE-CORONAVIRUS-2020-2E)
Proposals under this coordination and support action should support the international networking of existing, mainly longitudinal, cohorts in order to extract jointly agreed standardized data on COVID-19 diagnosed/serotyped and matched non-infected individuals. This effort should contribute to help in the identification of key factors influencing the susceptibility to infection and clinical manifestation, to assess the optimized therapeutic and clinical management options, and to derive lessons on the health and socio-economic impacts of the pandemic. They should develop cohort readiness to adapt rapidly to future crisis. Proposals should consider strategies to interact with the COVID-19 cohort(s) that will be funded under this expression of interest and international initiatives on cohorts, as well as liaising with the network of clinical trials on COVID-19.
Recommended grant: €2m-€3m
DFID’s Frontier Tech Hub #COVIDaction call
The Department for International Development‘s (DFID’s) Frontier Tech Hub #COVIDaction team, in partnership with the Royal Academy of Engineering, is seeking innovative approaches to shorten supply chains, pivot manufacturing, source raw materials and create new products to address demand in Low- and Middle-Income Countries. It has launched a call for Local Solutions: the call is seeking innovative, locally designed and produced solutions needed for COVID-19 response: PPE, components of PPE, parts to support production of PPE, and/or other solutions in response to local needs.
Applicants could receive up to £50,000 in grant funding, access to technical experts and match-making to DFID programmes, potential to be published in a virtual showcase and more.
The aim of #COVIDaction is to build a technology and innovation pipeline to support COVID-19 response. The team set out to scan for tech innovation in DFID countries (and globally), cut through the noise, make sense of ‘what’s working’ to then share what has been learned and uncovered as a global, public good.
Coronavirus business innovation support package
Grants and loans are available to Innovate UK award holders whose funded projects have been interrupted by Covid-19.
- Continuity grants: Up to £90 million is available in continuity grants, paid upfront, to SMEs and third sector organisations who are existing Innovate UK award holders and who are at risk of abandoning their project due to a sudden shortage or even unavailability of funds directly related to COVID-19. These grants are for eligible organisations that expect to have a funding gap (between £25,000 and £250,000) in the remaining period of their project because they are facing loss or damages, such as reduced access to capital, cancelled orders or increases to costs, and are therefore seeing cashflow disrupted as a result of the COVID-19 outbreak. Apply by 29th May 2020.
- Continuity loans: Up to £210 million is available in continuity loans to SMEs and third sector organisations that have a challenge in continuing a live project for which they are have an award from Innovate UK. Loans are for organisations that that find themselves facing a sudden shortage or even unavailability of funds resulting directly from the COVID-19 pandemic. This innovation continuity loan may be suitable if you need funding of between £250,000 and £1,600,000. These will be open until all the funds are allocated or until 31st December 2020, whichever is sooner.
For more details of the grants and loans available, click here.
COVID-19 Rapid Response Rolling Call - UKRI and NIHR
Building on the initial calls of their Initiative, DHSC, through the NIHR, and UKRI are jointly launching a rolling call for proposals for rapid research into COVID-19. As this is a rolling call there is currently no fixed end date to the call, we are open to applications and will aim to review complete proposals within 4 weeks of submission.
As of 22nd April, this also includes a specific call for research to investigate emerging evidence of an association between ethnicity and COVID-19 incidence and adverse health outcomes.
This call is for UK-led academic, SME and wider industry research that will address a wide range of COVID-19 knowledge gaps/needs, and which will lead to a benefit in UK, potentially international, public health within 12 months.
For more details, click here.
Travel and subsistence to support low and middle-income country engagement
The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries. The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation.
Applications are open until further notice, on a rolling basis. Applications should ideally be submitted at least 2 weeks before planned travel.
Click here for more details.
UKRI open call for research and innovation ideas to address COVID-19
UKRI will support excellent proposals of up to 18 months duration which meet at least one of the following:
- New research or innovation with a clear impact pathway that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, and response to, the COVID-19 pandemic and its impacts.
- Supports the manufacture and/or wide scale adoption of an intervention with significant potential
- Gathers critical data and resources quickly for future research use
Proposals will be accepted from anyone who is normally eligible to apply for UKRI funding. Proposals should be sent through this route for any research or innovation relevant to the above regardless of funding Council or whether relevant to multiple Councils.
There is no closing date – proposals can be submitted at any time.
For more information, click here.
Travel and subsistence funding to support LMIC academic engagement
These awards from NIHR will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries.
For more information, click here.
Business Wales Covid-19 Resilience Innovation Project Support
As part of the Welsh Government’s response to the Coronavirus outbreak, we are looking at supporting Innovative projects that can have a direct impact on how we fight the virus. The Covid-19 Resilience Innovation Project Support can be used to fund;
- The purchasing of specific equipment
- Adjustments to existing processes
- Implementation of new processes
The production of medical devices, Personal Protective Equipment (PPE) and the delivery of sanitising products are all potential areas that could be addressed by the support.
Closes 30th June 2020. No specific funding amount given. Only open to businesses in Wales.
For more information, click here.
Further worldwide funding opportunities
MIT Health Security & Pandemics Challenge – How can communities around the world prepare for, detect, and respond to emerging pandemics and health security threats? Prizes of up to $1m available. Closes 18th June 2020.
AWS Diagnostic Development Initiative – support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Reward – technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies. Initial submission period ends 30th June 2020.
Call for Code Global Challenge – mitigate the impact of COVID-19 and climate change by creating sustainable solutions using open source technology. $200k top prize, enter by 31st July 2020.
Competitive Fund for Peace and Recovery – Innovation for Poverty Action’s Peace & Recovery Program is accepting off-cycle proposals, capped at $50,000, for time-sensitive additions to research projects that study or support the COVID-19 response. Applications reviewed on a rolling basis.
Fast Funding for Covid-19 Science – A new venture fund is offering grants of $10,000 to $500,000 to coronavirus researchers, and every grant decision will be made in less than 48 hours. The fund, Fast Grants, has raised $10 million from 10 backers including Paul Graham, Stripe cofounders John and Patrick Collison, and LinkedIn cofounder Reid Hoffman. As of 16 April, applications are paused but may reopen in the future: check the site for updates and to sign up for notification of reopening. For more information, click here.